- Home
- CTMX vs BRIA Comparison
CTMX vs BRIA Comparison
Compare CTMX & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- BRIA
- Stock Information
- Founded
- CTMX 2008
- BRIA 2011
- Country
- CTMX United States
- BRIA Singapore
- Employees
- CTMX N/A
- BRIA N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- BRIA
- Sector
- CTMX Health Care
- BRIA
- Exchange
- CTMX Nasdaq
- BRIA NYSE
- Market Cap
- CTMX 444.3M
- BRIA 62.0M
- IPO Year
- CTMX 2015
- BRIA 2024
- Fundamental
- Price
- CTMX $2.42
- BRIA $2.38
- Analyst Decision
- CTMX Strong Buy
- BRIA
- Analyst Count
- CTMX 2
- BRIA 0
- Target Price
- CTMX $5.00
- BRIA N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- BRIA 2.8K
- Earning Date
- CTMX 08-07-2025
- BRIA 08-15-2025
- Dividend Yield
- CTMX N/A
- BRIA N/A
- EPS Growth
- CTMX 128.27
- BRIA N/A
- EPS
- CTMX 0.49
- BRIA 92.24
- Revenue
- CTMX $147,557,000.00
- BRIA $59,695,825.00
- Revenue This Year
- CTMX N/A
- BRIA N/A
- Revenue Next Year
- CTMX N/A
- BRIA N/A
- P/E Ratio
- CTMX $5.36
- BRIA $0.03
- Revenue Growth
- CTMX 23.81
- BRIA 8.03
- 52 Week Low
- CTMX $0.40
- BRIA $1.78
- 52 Week High
- CTMX $3.10
- BRIA $4.38
- Technical
- Relative Strength Index (RSI)
- CTMX 52.71
- BRIA N/A
- Support Level
- CTMX $2.33
- BRIA N/A
- Resistance Level
- CTMX $2.79
- BRIA N/A
- Average True Range (ATR)
- CTMX 0.18
- BRIA 0.00
- MACD
- CTMX -0.01
- BRIA 0.00
- Stochastic Oscillator
- CTMX 46.38
- BRIA 0.00
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.